申请人:Kinoyama Isao
公开号:US20120142727A1
公开(公告)日:2012-06-07
[Object] An excellent agent for preventing or treating dementia, schizophrenia, and the like, based on serotonin 5-HT
5A
receptor modulating action, is provided.
[Means for Solution] It was confirmed that acylguanidine derivatives (the following formula I; any one of Z
1
, Z
2
, Z
3
, Z
4
and Z
5
is nitrogen atom, and the others are carbon atoms) which have the characteristic structure in which the guanidine is bonded to one ring of the quinoline or isoquinoline via a carbonyl group, and a cyclic group is bonded to the other ring, exhibit potent 5-HT
5A
receptor modulating actions and excellent pharmacological actions based on the 5-HT
5A
receptor modulating action, and thus can be excellent agents for preventing or treating dementia, schizophrenia, bipolar disorder, or attention deficit hyperactivity disorder. Thus, the present invention has been completed.
提供一个基于调节5-HT5A受体的作用,用于预防或治疗痴呆、精神分裂症等的优秀药剂。[解决方案]确认了酰脒衍生物(以下公式I;Z1、Z2、Z3、Z4和Z5中的任何一个为氮原子,其余为碳原子)具有特征性结构,其中脒基通过羰基与喹啉或异喹啉的一个环连接,并且另一个环连接有环状基团,展现出强大的5-HT5A受体调节作用和基于5-HT5A受体调节作用的优秀药理作用,因此可作为预防或治疗痴呆、精神分裂症、双相情感障碍或注意力缺陷多动障碍的优秀药剂。因此,完成了本发明。